Morgan Stanley
CHTP

Morgan Stanley’s CHELSEA THERAPEUTICS INT'L LTD CHTP Stock Holding History

Morgan Stanley’s Portfolio CHTP Stock Details CHTP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		– Sell
-48,857
Closed -$270K – 6760
2014
Q1 		$270K Buy
48,857
+5,267
+12% +$26.4K ﹤0.01% 4945
2013
Q4 		$193K Sell
43,590
-199,458
-82% -$674K ﹤0.01% 5048
2013
Q3 		$727K Buy
243,048
+140,945
+138% +$405K ﹤0.01% 4063
2013
Q2 		$235K Buy
+102,103
New +$206K ﹤0.01% 4746

Other funds holding CHTP

Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
WA
Whitebox Advisors Minneapolis, Minnesota $8.12B AUM 15.85% 1-Year Est. Return
PAMP
Polar Asset Management Partners Toronto, Ontario, Canada $5.01B AUM 35.27% 1-Year Est. Return

Morgan Stanley's CHTP Position: Q2 2014 in Review

Morgan Stanley sold out of CHELSEA THERAPEUTICS INT'L LTD (CHTP) in Q2 2014, closing a stake of 48,857 shares — an estimated $270K sold.

Morgan Stanley first reported a position in CHTP in Q2 2013 and held it in 4 quarters. The position peaked at $727K in Q3 2013. 6 funds tracked by Wall St. Rank hold CHTP as of Q2 2014.

  • Morgan Stanley reported no remaining CHELSEA THERAPEUTICS INT'L LTD position as of Q2 2014 after selling out during the quarter.
  • Morgan Stanley sold 48,857 CHELSEA THERAPEUTICS INT'L LTD shares in Q2 2014, an estimated $270K.
  • Morgan Stanley first reported a position in CHELSEA THERAPEUTICS INT'L LTD in Q2 2013 and held it in 4 quarters.
  • Morgan Stanley's CHELSEA THERAPEUTICS INT'L LTD position peaked at $727K in Q3 2013.
  • 6 funds tracked by Wall St. Rank held CHELSEA THERAPEUTICS INT'L LTD as of Q2 2014.

Based on Morgan Stanley's 13F filing for Q2 2014, filed 12 Aug 2014.